Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Voortman Margarete Maria |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Reindl, M; Ropele, S; Enzinger, C; Khalil, M. High serum neurofilament light levels correlate with physical disability and brain atrophy in multiple sclerosis.
DocDay2022; FEB 10, 2022; Graz, AUSTRIA. 2022. [Onlinepräsentation]

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Khalil, M Serum Neurofilament Light Levels Correlate with Reduced Gray Matter Volume in Advanced Multiple Sclerosis
NEUROLOGY. 2021; 96(15): [Poster]
Web of Science FullText

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M P0156 - Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis.
MSVirtual (ACTRIMS/ECTRIMS joint meeting); SEP 15, 2020; Washington, DC, USA. 2020. [Poster]

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis.
17. Jahrestagung der ÖGN; SEP 20- 21, 2020; Salzburg, AUSTRIA. 2020. [Poster]

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Khalil, M Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis.
MULT SCLER J. 2020; 26(3_SUPPL):192-193.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Onlinepräsentation]
Web of Science

 

Buchmann, A; Pirpamer, L; Voortman, M; Pinter, D; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M #2630 Serum Neurofilament Light Correlates with Reduced Grey Matter Volume in Advanced Multiple Sclerosis.
European Journal of Neurology, May 2020. 2020; 27(Suppl1):45-45.-6th EAN Congress; MAY 23-25, 2020 ; Paris, FRANCE. [Oral Communication]
Web of Science FullText

 

Buchmann, A; Pirpamer, L; Voortman, M; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M Serum Neurofilament light correlates with reduced grey matter volume in advancing multiple sclerosis.
Doctoral Day 2019; 21.11.2019; Graz, AUSTRIA. 2019. [Poster]
FullText

 

Buchmann, A; Pirpamer, L; Voortman, M; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil M Serum Neurofilament light correlates with reduced grey matter volume in advancing multiple sclerosis.
47th Annual Meeting of the Austrian Society for Allergology and Immunology (ÖGAI); NOV 21-23, 2019; Graz, AUSTRIA. 2019. [Poster]
FullText

 

Khalil, M; Pirpamer, L; Hofer, E; Voortman, M; Barro, C; Leppert, D; Benkert, P; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, R; Kuhle, J Serum neurofilament light levels in normal aging: associations with morphologic brain changes
EUR J NEUROL. 2019; 26: 17-18. [Oral Communication]
Web of Science

 

Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Barro, C; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, R; Kuhle, J Serum neurofilament light levels in normal aging: associations with morphologic brain changes.
16. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 20-22, 2019; Eisenstadt, AUSTRIA. 2019. [Poster]

 

Stryeck, S; Voortman, M; Enzinger, C; Fuchs, S; Deisenhammer, F; Hegen, H; Fazekas, F; Madl, T; Khalil, M Serum NMR spectroscopy metabolomic profiles indicate progressive multiple sclerosis
EUR J NEUROL. 2019; 26: 241-241. [Poster]
Web of Science

 

Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H; Fazekas, F; Khalil, M Immunomodulatory therapy reduces elevated serum nitric oxide levels in multiple sclerosis patients.
Neurologisch. 2018; 2018(S1):63-63.-15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 21-23, 2018; Linz, AUSTRIA. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, HJ; Fazekas, F; Khalil, M Immunomodulatory therapy reduces elevated nitric oxide levels in multiple sclerosis patients
EUR J NEUROL. 2018; 25: 254-254.-4th Congress of the European Academy of Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL. [Poster]
Web of Science

 

Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H; Fazekas, F; Khalil, M Serum nitric oxide is increased in untreated in multiple sclerosis patients.
Abstract book CSF Society. 2018; 26. – Abstracts of the 2nd Meeting of the Society for CSF analysis and clinical neurochemistry (CSF Society); June 7-8, 2018; Amsterdam, The Netherlands. [Poster and Abstract].. 2018; 26-26.-2nd Meeting of the Society for CSF analysis and clinical neurochemistry; JUN 7-8, 2018; Amsterdam, THE NETHERLANDS. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, M.M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas, F; Khalil M Immunomodulatory therapy reduces elevated NOX levels in multiple sclerosis patients
2nd Meeting of the Society for CSF analysis and clinical neurochemistry ; JUN 7-8, 2018; Amsterdam. 2018. [Poster]
FullText

 

Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Hallwirth, F; Barro, C; Fazekas, F; Schmidt, R; Kuhle, J Normative values of serum neurofilament light levels
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):657-658.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science FullText

 

Voortman, M; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos-Garcia, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early Multiple Sclerosis (MS)
EUR J NEUROL. 2018; 25: 434-434.-4th Congress of the European-Academy-of-Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL. [Oral Communication]
Web of Science

 

Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):255-255.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science FullText

 

Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger; C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying treatment on CD62L expression in multiple sclerosis
Abstract book Doctoral Day Retrain the Brain 2018. 2018; 64-64.-Doctoral Day Retrain the Brain; NOV 28, 2018; Graz, AUSTRIA. [Poster]
FullText

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, J-J; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Abstract book 2nd Meeting of the Society for CSF analysis and clinical neurochemistry. 2018; 73-73.-2nd Meeting of the Society for CSF analysis and clinical neurochemistry; JUN 7-8, 2018; Amsterdam, THE NETHERLANDS. [Poster]
FullText

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Neurologisch. 2018; 2018(S1):61-61.-15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 21-23, 2018; Linz, AUSTRIA. [Poster]
FullText

 

Fissolo, N; Issazadeh-Navikas, S; Dujmovic, I; Voortman, MM; Khalil, M; Montalban, X; Comabella, M. Serpina3n: potential biomarker in patients with progressive multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):219-219.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

Gattringer, T; Pinter, D; Enzinger, C; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Grobke, S; Voortman, M; Seifert-Held, T; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M Serum neurofilament light chain protein: A promising biomarker for lacunar stroke and cerebral small vessel disease.
EUR J NEUROL. 2017; 24: 462-462.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Oral Communication]
Web of Science

 

Gattringer, T; Pinter, D; Enzinger, C; Seifert-Held, T; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Gröbke, S; Voortman, M; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M Serum neurofilament light chain protein: A promising biomarker for lacunar stroke and cerebral small vessel disease.
European Stroke Journal. 2017; 2(IS):227-227.-3rd European Stroke Organisation Conference; MAY 16-18, 2017; Prague, Czech Republic. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas; Khalil, M Serum nitric oxide is increased in untreated multiple sclerosis patients.
Mult Scler J. 2017; 23(S3):586-587.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science

 

Leurs CE; Twaalfhoven, HAM; Witte, BI; Van Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, PE; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La Puma, D; Vercammen, MJ; VanopdenBosch, L; Uitdehaag, BMJ; Killestein, J; Teunissen, C. Kappa free light chains: an automated alternative to oligoclonal bands for CIS and MS diagnosis?
Multiple Sclerosis Journal. 2017; 23(S3):591-592.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Poster]
Web of Science FullText

 

Voortman, MM; Pekar, T; Bachmayer D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
Neurologisch. 2017; 2017(S2):50-51.-14. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Mar 22-24, 2017; Villach, Austria; MAR 22-24, 2017; Villach, AUSTRIA. [Oral Communication]

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Doctoral day of the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM. [Poster]
Web of Science

 

Voortman, MM; Bachmayer, D; Pekar, T; Seifert-Held, T; Archelos, J-J; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M The role of serum Netrin-1 in early multiple sclerosis.
Doctoral day Medical University of Graz; DEC 14, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

 

Voortman, MM; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M The role of serum Netrin-1 in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]
FullText

 

Voortman, MM; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
Multiple Sclerosis Journal. 2016; 22(S3):274-274.-32nd congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM. [Poster]
FullText

 

Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]
FullText

 

Stojakovic, T; Voortman, MM; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Hematology Reports. 2015; 7(S1):67-67.-7th International Symposium on Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis; APR 16-17, 2015; Edinburgh, UNITED KINGDOM. [Poster]

 

Voortman, M M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M. Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA. 2015. [Poster]

 

Voortman, M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos-Garcia, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
EUR J NEUROL. 2015; 22: 398-398.-1st Congress of the European Academy of Neurology (EAN); JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

Voortman, M.M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J.J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Eur J Neurol. 2015; 22(S1):398-398.-1st Congress of the European Academy of Neurology (EAN); JUN 20-23, 2015; Berlin, GERMANY. [Poster]

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid immunoglobulin free light chains as diagnostic and prognostic tool in clinically isolated syndrome and multiple sclerosis.
Inflame Symposium on Inflammation & Immunology; SEP 14-15, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Neurologisch, Supplementum 2/2015. 2015; 2: 25-25.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27, 2015; Graz, AUSTRIA. [Poster]

 

Voortman, MM; Stojakovic, T;Jehna, M;Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients.
Multiple Sclerosis Journal. 2015; 21(S11):630-630.-31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 7-10, 2015; Barcelona, SPAIN. [Poster]
FullText

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum